DR. JACK D. LENNOX, D.O.

Plain English
This paper discusses how the National Institutes of Health (NIH) created guidelines for treating COVID-19, responding to a need for expert advice when the disease first emerged in 2020. Over four years, the NIH panel developed and updated treatment recommendations, addressing ongoing challenges and questions about COVID-19. Now that the pandemic's public health emergency has ended, other healthcare organizations will take over the responsibility of updating these treatment guidelines. Who this helps: This helps doctors and healthcare professionals who treat COVID-19 patients.

Plain English
This study looked at how two immune-modulating drugs, ruxolitinib and sirolimus, might change the shedding of cytomegalovirus (CMV) in people with HIV who are on antiretroviral therapy. Researchers analyzed 635 samples and found no significant changes in CMV levels with the treatments, but noticed that men shed more CMV than women. The findings highlight that higher levels of CMV are linked to worse health outcomes in people with HIV. Who this helps: This research benefits healthcare providers and researchers studying HIV and its related complications.

Plain English
This study looked at the variety of microorganisms in soil and bark across different vineyards and found that the type of habitat (like soil vs. bark) influences the types of microbes present more than the distance between sites or how the vineyards are managed (like organic versus conventional farming). They analyzed a huge amount of data from 108 samples and concluded that while microbial communities were different in various locations, the distance between those locations didn't affect the differences seen, treating each vineyard site as an "island" of biodiversity. This matters because understanding these microbial communities can help improve vineyard management and enhance soil health. Who this helps: This helps vineyard owners and agricultural scientists.

Plain English
This study looked at how the drug ruxolitinib behaves in the body of HIV-positive individuals who are already on treatment to control their virus. Researchers found that the way ruxolitinib is cleared from the body differs depending on the type of HIV treatment used; specifically, it was cleared faster in people taking efavirenz compared to those on integrase inhibitors. This is important because it suggests that using integrase inhibitors might be a better choice for people taking ruxolitinib, helping ensure they receive the right medication levels. Who this helps: Patients living with HIV who may also need to take ruxolitinib for inflammation.

Plain English
This paper examines how the COVID-19 pandemic changed education, leading to the development of new flexible learning methods. It highlights the importance of investing in educators and better data systems to support these changes. By using economic analysis and expanding partnerships, education systems can become more resilient and improve access to learning for all students. Who this helps: This helps students, teachers, and education policymakers.

Plain English
This study developed and tested a new questionnaire called the Body Compassion Questionnaire (BCQ) to measure how people feel compassion towards their bodies. Researchers found that higher BCQ scores, especially in the area of body kindness, were linked to fewer negative emotions about body image and better eating behavior. This matters because using the BCQ can help identify individuals at risk for eating disorders and improve treatments aimed at body image issues. Who this helps: This benefits patients struggling with body image and eating disorders, as well as healthcare providers working in these areas.

Plain English
Researchers studied the levels of HIV medications found in patients' hair to see if they could predict how well the treatment would work. They found that higher concentrations of these medications in hair were strongly linked to better treatment outcomes, demonstrating this connection for the first time in a large clinical trial. This matters because it provides a new way to assess whether patients are responding well to treatment, which can lead to better care for people living with HIV. Who this helps: This helps patients with HIV and their healthcare providers.

Plain English
This study looked at people living with HIV who continued to lose CD4+ T cells even though their virus levels were well-controlled by medication. The researchers found that, after about four years on treatment, these individuals lost an average of 157 CD4+ T cells per microliter, while those who responded well to treatment gained CD4+ cells. Understanding this unusual decline is important because it can help improve the care of patients who face such challenges despite appearing to be successfully treated for HIV. Who this helps: This helps patients with HIV who experience unexplained declines in their immune cell counts.

Plain English
This study looked at how genetic differences in the CYP2B6 gene affect people's reactions to efavirenz, a common medication for treating HIV. It found that patients with certain genetic variants of CYP2B6 are more likely to experience harmful side effects related to the brain, which might lead them to stop taking the medication. This is important because tailoring HIV treatment based on a patient’s genetics can improve safety and effectiveness. Who this helps: Patients taking efavirenz for HIV treatment.

Plain English
This study looked at the relationship between bilirubin levels and the risk of heart problems in both people living with HIV and those without it. The researchers found that higher bilirubin levels were linked to a lower risk of cardiovascular disease events, with a notable decrease in risks for conditions like heart failure and strokes. Specifically, for every increase in bilirubin quartile, there was a 14% lower risk of heart-related events. This is important because it suggests that bilirubin could have protective benefits against heart disease, which is a significant health concern for both HIV-positive and HIV-negative individuals. Who this helps: Patients at risk for cardiovascular disease, including those with HIV.

Plain English
This study looked at how young women aged 18-29 in Glasgow use drinking to shape their identities, especially in the context of social media. Researchers found that these women often feel pressure to balance being fun and appealing with maintaining respectability, which is more challenging for working-class women who face harsher judgments. By examining 21 focus groups and individual interviews, the study highlights how social media amplifies scrutiny around women’s drinking behaviors and appearances, affecting how they see themselves and are seen by others. Who this helps: This benefits young women navigating social pressures, as well as their friends and families who support them.

Plain English
This study looked at whether a weight management program, adapted from a successful men's program, could work for women when delivered by professional football clubs. Out of 123 women who joined the program, 94 completed it, with participants losing an average of 2.87 kg and reducing their waist size by an average of 3.84 cm over 12 weeks. These results show that this program is feasible and effective, offering a positive alternative to existing weight loss options. Who this helps: Women struggling with obesity.

Plain English
This study looked at how LGBT people view their drinking habits and the role alcohol plays in shaping their identities. Researchers found that heavy drinking is seen as a key part of gay social life, with specific drinks associated with different identities—like gay men preferring cocktails and lesbians opting for beer. Understanding these social pressures is important for creating effective programs to help reduce alcohol-related issues in the LGBT community. Who this helps: This helps LGBT individuals and those designing health programs for them.

Plain English
This study focused on the eating habits and beliefs about nutrition during pregnancy among Maasai women in Northern Tanzania. The researchers interviewed 12 pregnant women and found key insights: many believe that eating less can make childbirth easier and that hard work could harm their babies. These findings highlight the importance of addressing nutritional needs during pregnancy in this community and suggest that health programs should respect and incorporate their traditional practices to be effective. Who this helps: This helps pregnant Maasai women and healthcare providers working in their communities.

Plain English
Researchers studied healthy individuals with HIV who were receiving effective treatment (HAART) to see if the virus was present in immune cells in the lungs and how that affected the cells' ability to fight infections. They found that 16 out of 23 subjects had traces of the virus in their lung immune cells, and those with the virus had a significantly lower ability to engulf pathogens compared to those without the virus (11.8 vs. 64.9 on a phagocytic index). This matters because it shows that even with treatment, HIV can persist in the lungs and weaken immune responses, increasing the risk of lung infections. Who this helps: This helps patients with HIV by highlighting potential complications in lung health even when the virus is well-managed in the bloodstream.

Plain English
This study examined how the fluid from the lungs of healthy people with HIV-1 differed from that of healthy people without HIV-1. Researchers found 115 specific chemicals that were significantly different in the lung fluid of HIV-1-infected individuals compared to controls. This matters because it may help identify lung infections or changes in lung health in people with HIV-1, even when their blood tests show normal results. Who this helps: This helps patients with HIV-1 and their doctors in monitoring lung health.

Plain English
This study looked at how HIV infection and anti-retroviral therapy (ART) affect levels of important antioxidants in the lungs, specifically glutathione and cysteine. The researchers found that while both HIV-infected individuals and those without HIV showed similar levels of these antioxidants, those on ART had much higher glutathione levels (about 367.4 nM) compared to those not on ART (about 30.8 nM). This is significant because lower antioxidant levels in the lungs can indicate a higher risk for lung infections, which are a major threat to people with HIV. Who this helps: This research benefits patients with HIV by highlighting the importance of ART for lung health.

Plain English
This study focused on a new step training system designed to assess and reduce the risk of falls in older adults. Researchers found that over one-third of people aged 65 and older fall each year, and their new program encourages older adults to actively participate in exercises at home. While early tests showed that older adults were interested in using the system, some challenges with ongoing use were identified. Who this helps: This benefits older adults at risk of falling and their caregivers.

Plain English
This study looked at the Mellow Parenting Programme to see if it could help school-age children with Reactive Attachment Disorder (RAD), a serious condition often caused by neglect or abuse. While mothers showed improved mental health, the programme did not significantly change symptoms of RAD or parent-child interactions for most families. The results suggest that while Mellow Parenting can support mothers, it isn't a proven solution for treating RAD in older children. Who this helps: This is useful for families dealing with Reactive Attachment Disorder and the professionals who support them.

Plain English
This study explored how well certain patients respond to a specific combination of HIV treatments in a group of 287 people who hadn't received HIV medication before. It found that 72% of patients were able to reduce their HIV levels to very low or undetectable levels after 48 weeks of treatment, especially if they adhered to their medication and had graduated high school. It also highlighted that those with lower initial HIV levels and higher CD4 counts had better outcomes, while men with less education and more advanced HIV were less likely to do well. Who this helps: This information benefits patients and doctors by identifying factors that can improve treatment success for people starting HIV therapy.

Plain English
This study looked at how certain immune cells, called CD4 T cells, respond to HIV in two groups of people: those who control the virus effectively (controllers) and those who do not (noncontrollers). The researchers found that in controllers, more than half of these cells produce three important signaling molecules, while in noncontrollers, about 75% of the cells only produce one signaling molecule. This matters because having more cells that produce three signaling molecules is linked to better control of HIV and lower levels of the virus in the body. Who this helps: This helps patients living with HIV, especially those struggling to control the virus.

Plain English
This study looked at different treatments to help adults with HIV control the virus without relying solely on daily medication. Researchers tested 81 participants, and those who received a specific vaccine (ALVAC) had a 0.5 log(10) lower viral rebound compared to those who didn't get the vaccine, indicating better control of the virus. While the combination of an interleukin-2 treatment and the vaccine increased certain immune cells, it didn't significantly reduce the virus levels after stopping the medication. Who this helps: This benefits HIV patients looking for alternatives to continuous antiretroviral therapy.

Plain English
This study looked at patients in the southeastern United States who were diagnosed with a primary human immunodeficiency virus (HIV) infection. Researchers found that most patients (83%) were diagnosed only after multiple visits—often three or more—to healthcare providers, and only 17% were diagnosed correctly at their first visit. This matters because earlier diagnosis of HIV can lead to better management and treatment, improving health outcomes for those affected. Who this helps: This helps patients, especially those at risk of HIV, by highlighting the need for quicker diagnosis.

Plain English
This study focused on improving the monitoring of wastewater treatment plants, which often face challenges due to complex biological processes and unpredictable changes. Researchers developed a new algorithm called Adaptive Multiscale Principal Components Analysis (AdMSPCA), finding that it could quickly adapt to various changes in the system, making it more effective than standard methods. Specifically, AdMSPCA was better at detecting slower changes, which is crucial for maintaining the efficiency of wastewater treatment. Who this helps: This benefits wastewater treatment facilities and the environment by improving their operational monitoring.

Plain English
This study looked at specific parts of the HIV virus to see how well the immune system recognizes them at different stages of infection. Researchers tested blood samples from 75 HIV-infected people and found that a certain part of the virus was recognized by 100% of them, with an antibody level that was about 100,000 times higher than others. The study also discovered that in the early stages of HIV infection, 62% of samples reacted strongly to one particular viral part, while only 11% did in the later stages, which could help in understanding and diagnosing the infection's progression. Who this helps: This research benefits patients and doctors by improving HIV testing and treatment strategies.